BR112020016954A2 - Variantes de tripsina suína - Google Patents

Variantes de tripsina suína Download PDF

Info

Publication number
BR112020016954A2
BR112020016954A2 BR112020016954-4A BR112020016954A BR112020016954A2 BR 112020016954 A2 BR112020016954 A2 BR 112020016954A2 BR 112020016954 A BR112020016954 A BR 112020016954A BR 112020016954 A2 BR112020016954 A2 BR 112020016954A2
Authority
BR
Brazil
Prior art keywords
seq
amino acid
insulin
group
variant
Prior art date
Application number
BR112020016954-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Thomas Stillger
Sebastian RISSOM
Claudia Feller
Andreas Vogel
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of BR112020016954A2 publication Critical patent/BR112020016954A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21004—Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
BR112020016954-4A 2018-02-22 2019-02-22 Variantes de tripsina suína BR112020016954A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18158034 2018-02-22
EP18158034.1 2018-02-22
PCT/EP2019/054400 WO2019162423A1 (en) 2018-02-22 2019-02-22 Variants of porcine trypsin

Publications (1)

Publication Number Publication Date
BR112020016954A2 true BR112020016954A2 (pt) 2020-12-29

Family

ID=61274085

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112020016954-4A BR112020016954A2 (pt) 2018-02-22 2019-02-22 Variantes de tripsina suína

Country Status (13)

Country Link
US (2) US11518988B2 (cg-RX-API-DMAC7.html)
EP (1) EP3755794A1 (cg-RX-API-DMAC7.html)
JP (2) JP7432516B2 (cg-RX-API-DMAC7.html)
KR (1) KR102863070B1 (cg-RX-API-DMAC7.html)
CN (1) CN111989401A (cg-RX-API-DMAC7.html)
AU (1) AU2019225972B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020016954A2 (cg-RX-API-DMAC7.html)
CA (1) CA3091943A1 (cg-RX-API-DMAC7.html)
IL (1) IL276799A (cg-RX-API-DMAC7.html)
MX (1) MX2020008766A (cg-RX-API-DMAC7.html)
MY (1) MY200951A (cg-RX-API-DMAC7.html)
SG (1) SG11202008026WA (cg-RX-API-DMAC7.html)
WO (1) WO2019162423A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019162423A1 (en) 2018-02-22 2019-08-29 Sanofi-Aventis Deutschland Gmbh Variants of porcine trypsin
CN111676211B (zh) * 2020-05-15 2022-07-19 天津科技大学 一种抗自切和高比活力胰蛋白酶突变体
CN119552847B (zh) * 2025-01-21 2025-04-11 四川大学 链霉菌胰蛋白酶自剪切位点突变体及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010022452A (ko) * 1997-07-31 2001-03-15 추후제출 플라비바이러스 감염에 대한 재조합 다이머형 엔벨롭 백신
US7622113B2 (en) * 2003-12-08 2009-11-24 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies that bind or neutralize dengue virus
ATE517919T1 (de) * 2005-09-14 2011-08-15 Sanofi Aventis Deutschland Spaltung von insulinvorstufen durch eine trypsinvariante
BR112013009649A2 (pt) * 2010-10-29 2016-07-12 Merck Sharp & Dohme composição imunogênica, métodos para provocar uma resposta imune protetora em um paciente humano e para fornecer proteção imune em seres humanos contra doença, e, uso de uma composição
US9267114B2 (en) * 2012-11-07 2016-02-23 Southern Research Institute Flavivirus envelope protein mutations affecting virion disassembly
WO2019162423A1 (en) * 2018-02-22 2019-08-29 Sanofi-Aventis Deutschland Gmbh Variants of porcine trypsin

Also Published As

Publication number Publication date
RU2020130880A (ru) 2022-03-22
CA3091943A1 (en) 2019-08-29
US11952602B2 (en) 2024-04-09
JP7699196B2 (ja) 2025-06-26
MX2020008766A (es) 2020-12-07
KR20200124255A (ko) 2020-11-02
US20200377873A1 (en) 2020-12-03
RU2020130880A3 (cg-RX-API-DMAC7.html) 2022-03-22
NZ768123A (en) 2026-02-27
SG11202008026WA (en) 2020-09-29
JP2021514194A (ja) 2021-06-10
KR102863070B1 (ko) 2025-09-22
AU2019225972A1 (en) 2020-10-15
JP2024038140A (ja) 2024-03-19
US20230303994A1 (en) 2023-09-28
AU2019225972B2 (en) 2024-10-17
WO2019162423A1 (en) 2019-08-29
MY200951A (en) 2024-01-25
CN111989401A (zh) 2020-11-24
EP3755794A1 (en) 2020-12-30
IL276799A (en) 2020-10-29
US11518988B2 (en) 2022-12-06
JP7432516B2 (ja) 2024-02-16

Similar Documents

Publication Publication Date Title
JP7699196B2 (ja) ブタトリプシンの変異体
JP7252280B2 (ja) 新規なインスリンアナログ及びその用途
KR102811896B1 (ko) 병리학적 석회화 병태를 치료하기 위한 조성물, 및 이의 사용 방법
JP5117563B2 (ja) 修飾成長ホルモン
JP7158378B2 (ja) インスリン受容体との結合力が減少された、インスリンアナログ及びその用途
Mikiewicz et al. Soluble insulin analogs combining rapid-and long-acting hypoglycemic properties–From an efficient E. coli expression system to a pharmaceutical formulation
AU2011263786A1 (en) Tear lipocalin muteins binding IL-4 r alpha
KR20230017804A (ko) Rhfgf21 융합 단백질, rhfgf21 융합 단백질을 인코딩하는 폴리뉴클레오티드, rhfgf21 융합 단백질을 포함하는 조성물, 및 rhfgf21 융합 단백질의 용도
JP2013515474A (ja) 組換え体h因子ならびにそのバリアントおよびコンジュゲート
CN118302522B (zh) IgA蛋白酶截短体、包含IgA蛋白酶截短体的融合蛋白及其用途
CN115515616A (zh) 乌司他丁多肽
CN118302523B (zh) 包含IgA蛋白酶截短体的融合蛋白及其用途
Xu et al. Expression, purification, and characterization of recombinant lumbrokinase PI239 in Escherichia coli
RU2783315C2 (ru) Варианты свиного трипсина
CN114096556B (zh) 表皮生长因子受体(egfr)配体
EP3500284A1 (en) Bovine fibroblast growth factor 21 and ketosis in dairy cattle
KR100407792B1 (ko) 인간 글루카곤 유사펩타이드를 융합파트너로 이용한재조합 단백질의 제조방법
CN119546286A (zh) Klk1融合蛋白的制备方法
JP2012504409A (ja) ソマトスタチン類似体

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]